UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006263
Receipt number R000007414
Scientific Title Effect of Diffuse-Chorioamniotic-Hemosiderosis on the development of chronic lung disease in premature infants
Date of disclosure of the study information 2011/09/05
Last modified on 2015/10/28 10:08:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Diffuse-Chorioamniotic-Hemosiderosis on the development of chronic lung disease in premature infants

Acronym

Diffuse-Chorioamniotic-Hemosiderosis and chronic lung disease in premature infants

Scientific Title

Effect of Diffuse-Chorioamniotic-Hemosiderosis on the development of chronic lung disease in premature infants

Scientific Title:Acronym

Diffuse-Chorioamniotic-Hemosiderosis and chronic lung disease in premature infants

Region

Japan


Condition

Condition

diffuse chorioamniotic hemosiderosis

Classification by specialty

Obstetrics and Gynecology Pediatrics Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

effect on the development of chronic lung disease in premature infants

Basic objectives2

Others

Basic objectives -Others

pathology of placenta

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

severity of chronic lung disease in premature infants

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

0 weeks-old <=

Age-upper limit

0 weeks-old >=

Gender

Male and Female

Key inclusion criteria

birth weight under 1,500g

Key exclusion criteria

chromosome aberration
metabolic disorder
multiple anomaly

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tatsuya Watanabe

Organization

Tohoku university hospital

Division name

neonatal center for perinatal medicine

Zip code


Address

1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574 Japan

TEL

022-717-7287

Email

tatsu-w@med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tatsuya Watanabe

Organization

Tohoku university hospital

Division name

neonatal center for perinatal medicune

Zip code


Address

1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574 Japan

TEL

022-717-7287

Homepage URL


Email

tatsu-w@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku university

Institute

Department

Personal name



Funding Source

Organization

national institute of public health

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学病院(宮城県)、仙台赤十字病院(宮城県)、宮城県立こども病院(宮城県)


Other administrative information

Date of disclosure of the study information

2011 Year 09 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2011 Year 09 Month 05 Day

Date of IRB


Anticipated trial start date

2011 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

lung injury of premature infants before birth
pathology of placenta
clinical characteristic of chronic lung disease in premature infants


Management information

Registered date

2011 Year 08 Month 31 Day

Last modified on

2015 Year 10 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007414


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name